Biomedical Advanced Research and Development Authority logo
BARDA DRIVe ImmuneChip+

BARDA DRIVe ImmuneChip+ (through

Supports creators of immune-enabled organ-on-chip systems and biosensing manufacturing for critical health technology challenges.

The BARDA DRIVe ImmuneChip+ program is an open Broad Agency Announcement (BAA) administered by the Biomedical Advanced Research and Development Authority's Division of Research, Innovation, and Ventures, accepting proposals on a rolling basis through September 28, 2028. The program funds advanced in vitro microphysiological systems — commonly known as organ-on-chip platforms — that incorporate imm…

Advanced in vitro microphysiological systems incorporating immune components — including organ-on-chip platforms with automated manufacturing, biosensors, and multi-tissue integration — for CBRN medical countermeasure development.

CycleiHow often this grant runs — e.g. annually, on a rolling basis, or a one-off call.Rolling
Next deadlineiThe next date applications are due. Rolling means you can apply any time.28 Sept 2028
Decision timeiTypical time from the deadline to the funder's decision.—
Project durationiHow long the funded work is expected to run.—
Award typeiThe form of funding — grant, equity, loan, tax credit, etc.Procurement contract
Match fundingiThe share of project costs you must cover yourself. 0% = fully funded.0%
Funding pooliThe total budget available across all awards in this round.—

Sign up free to see the funding breakdown

Sign up free to see the industries in scope

Sign up free to see the full eligibility

Sign up free to see the timeline

Last verified: 24 Jul 2026Source: drive.hhs.gov